Skip to end of metadata
Go to start of metadata




1a. Project Name

Skin and Wound Assessment PSS

1b. Project ID

1584

1c. Is Your Project an Investigative Project (aka PSS-Lite)?

No

1d. Is your Project Artifact being Reaffirmed or proceeding to Normative directly after being either Informative or STU?

No

1e. Today's Date

1f. Name of standard being reaffirmed

1g. Project Artifact Information

1h. ISO/IEC Standard to Adopt

1i. Does the standard include excerpted text from one or more ISO, IEC or ISO/IEC standards, but is not an identical or modified adoption?

1j. Unit of Measure

2a. Primary/Sponsor WG

Patient Care

2b. Co-Sponsor WG

Clinical Information Modeling Initiative

2c. Co-Sponsor Level of Involvement

Request formal content review prior to ballot

2b. Co-Sponsor WG 2

Electronic Health Record

2c. Co-Sponsor Level of Involvement

Request periodic project updates; specify period in text box below (e.g. 'Monthly', 'At WGMs', etc.)

2c. Co-Sponsor 2 Update Periods

Weekly as appropriate

2b. Co-Sponsor WG 3

Clinical Interoperability Council

2c. Co-Sponsor Level of Involvement

Request periodic project updates; specify period in text box below (e.g. 'Monthly', 'At WGMs', etc.)

2d. Project Facilitator

Susan Matney

2e. Other Interested Parties (and roles)

Michael Brody, DPM. CEO Registry Clearinghouse

2f. Modeling Facilitator

Nathan Davis

2g. Publishing Facilitator

Patrick Langford

2h. Vocabulary Facilitator

Susan Matney

2i. Domain Expert Representative

National Pressure Ulcer Advisory Panel

2j. Business Requirements Analyst

2k. Conformance Facilitator

2l. Other Facilitators

2m. Implementers

Tissue Analytics
Intermountain Heatlhcare

3a. Project Scope

To develop a skin and wound assessment model and FHIR profiles which can be used to document, track and trend wound care across settings.

This FHIR implementation guide will use the US Core profiles. If this FHIR implementation guide is unable to use a US Core profile we will request approval from US Realm SC, and provide the US Realm approved rationale for deviation in the implementation guide where applicable.

Attachments

3b. Project Need

Wound care is a clinical domain of high interest because iatrogenic skin and tissue breakdowns (e.g., pressure ulcers) and the mitigation of risk for skin breakdown are recognized as indicators of quality. The National Quality Forum endorsed pressure ulcers as a nursing sensitive outcome measure, and the Centers for Medicare and Medicaid Services (CMS) view hospital acquired pressure ulcers as a preventable hospital acquired condition for which hospitals no longer receive added reimbursement.

Wounds are also cared for across settings. Wounds are documented in three different apps within Intermountain Healthcare, one of which is Tissue Analytics - therefore, Intermountain would like to implement the FHIR profiles within their enterprise.

3c. Security Risk

No

3d. External Drivers

Veteran's Administration, National Pressure Ulcer Advisory Panel, Podiatrists

3e. Objectives/Deliverables and Target Dates

1. Develop the logical model (complete)
2. Curate the needed terminology content with LOINC and SNOMED CT (complete).
3. Test the FHIR profiles during a connectathon (Done in Montreal)
4. Create R4 FHIR profiles and IG - first draft done 1/31/2020
5. Enhance FHIR profile for implementers, including expanding body locations (in progress, target is 3/15/2020).
6. Develop the IG (target date 3/28/2020)
7. Connectathon - September 2020
8. Ballot in Sept 2020

3f. Common Names / Keywords / Aliases:

Wound Assessment

3g. Lineage

3h. Project Dependencies

3i. HL7-Managed Project Document Repository URL:

https://github.com/HL7/fhir-skin-wound-ig

3j. Backwards Compatibility

No

3k. Additional Backwards Compatibility Information (if applicable)

3l. Using Current V3 Data Types?

N/A

3l. Reason for not using current V3 data types?

3m. External Vocabularies

Yes

3n. List of Vocabularies

SNOMED CT, SNOMED CT HSPC extension
LOINC
UCUM

3o. Earliest prior release and/or version to which the compatibility applies

4a. Products

FHIR Implementation Guide, FHIR Profiles

4b. For FHIR IGs and FHIR Profiles, what product version(s) will the profiles apply to?

v4

4c. FHIR Profiles Version

4d. Please define your New Product Definition

4d. Please define your New Product Family

5a. Project Intent

Create new standard

5a. White Paper Type

5a. Is the project adopting/endorsing an externally developed IG?

5a. Externally developed IG is to be (select one)

5a. Specify external organization

5a. Revising Current Standard Info

5b. Project Ballot Type

STU to Normative

5c. Additional Ballot Info

https://github.com/HL7/fhir-skin-wound-ig

5d. Joint Copyright

Yes

5e. I understand I must submit a Joint Copyright Letter of Agreement to the TSC in order for the PSS to receive TSC approval.

Yes

6a. External Project Collaboration

National Pressure Ulcer Advisory Panel
Wound care nurses at the Veteran's administration as subject matter experts.

6b. Content Already Developed

90

6c. Content externally developed?

No

6d. List Developers of Externally Developed Content

Nursing Knowledge Big Data Science Initiative
Solor content developers (Keith Campbell, Susan Matney, et al.)
Intermountain Healthcare
Podiatrists

6e. Is this a hosted (externally funded) project?

No

6f. Stakeholders

Quality Reporting Agencies, Regulatory Agency, Standards Development Organizations (SDOs), Payors

6f. Other Stakeholders

6g. Vendors

EHR, PHR

6g. Other Vendors

6h. Providers

Emergency Services, Healthcare Institutions (hospitals, long term care, home care, mental health)

6h. Other Providers

6i. Realm

U.S. Realm Specific

7d. US Realm Approval Date

Feb 25, 2020

7a. Management Group(s) to Review PSS

FHIR

7b. Sponsoring WG Approval Date

May 23, 2019

7c. Co-Sponsor Approval Date

May 23, 2019

7c. Co-Sponsor 2 Approval Date

May 28, 2019

7c. Co-Sponsor 3 Approval Date

May 23, 2019

7c. Co-Sponsor 4 Approval Date

7c. Co-Sponsor 5 Approval Date

7c. Co-Sponsor 6 Approval Date

7c. Co-Sponsor 7 Approval Date

7c. Co-Sponsor 8 Approval Date

7c. Co-Sponsor 9 Approval Date

7c. Co-Sponsor 10 Approval Date

7e. CDA MG Approval Date

7f. FMG Approval Date

Nov 13, 2019

7g. V2 MG Approval Date

7h. Architecture Review Board Approval Date

7i. Steering Division Approval Date

Mar 09, 2020

7j. TSC Approval Date

Mar 16, 2020